Related Experiment Video
Updated: Jul 29, 2026

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation
Published on: May 3, 2024
Apoptotic myocardial degeneration in thrombotic thrombocytopenic purpura
1World Health Organization Cardiovascular Center, the Department of Medicine, University of Texas Medical Branch, Galveston 77555-0129, USA.
Insights
Thrombotic thrombocytopenic purpura (TTP) causes myocardial degeneration primarily through apoptosis, not necrosis. This finding offers insights into cardiac issues and reperfusion injuries.
Area of Science:
- Cardiovascular Pathology
- Cellular Biology
- Hematology
Background:
- Thrombotic thrombocytopenic purpura (TTP) frequently involves cardiac complications, including the conduction system.
- Despite coronary artery platelet occlusions, TTP shows minimal myocardial necrosis, posing a diagnostic challenge.
Purpose of the Study:
- To investigate if apoptosis is the underlying mechanism of myocardial degeneration observed in TTP.
- To elucidate the cellular processes contributing to cardiac involvement in TTP.
Main Methods:
- Examination of six TTP patient hearts using routine and immunohistochemical staining.
- Analysis of myocardial and cardiac conduction system tissues, including sinus node, AV node, and His bundle.
Main Results:
- Widespread platelet thrombi occluding small coronary arteries, particularly in the cardiac conduction system.
- Myocardial degeneration characterized by lack of inflammation and intact myocytes, with TUNEL-positivity indicating apoptosis.
- Focal myocardial degeneration in TTP is predominantly apoptotic.
Conclusions:
- The cardiac degeneration in TTP is primarily driven by apoptosis.
- Serotonin release from platelet aggregation may influence early platelet aggregations, potentially impacting cardiac events.
- Findings may inform understanding of myocardial reperfusion injuries in procedures like angioplasty and thrombolysis.
Abstract:
The objective of this study was to determine whether the known myocardial degeneration in TTP is due to apoptosis. In TTP the heart is often involved, including the cardiac conduction system. Despite many platelet occlusions of small coronary arteries, there is little myocardial necrosis. Why the intermittent clinical episodes begin or end is unknown. Six hearts of patients dying with TTP were examined with routine and immunohistochemical stains. In addition to ventricular and atrial myocardium we examined the cardiac conduction system and coronary chemoreceptor. Numerous small coronary arteries were occluded with platelet thrombi in all these sites, including especially the sinus node, AV node and His bundle. The myocardial degeneration we found was conspicuously devoid of inflammation and the myocytes were relatively intact. These characteristics combined with TUNEL-positivity in the degenerating cells are typical of apoptosis. The focal degeneration in TTP is primarily apoptotic. Because circulating serotonin is carried by platelets and is released during aggregation, and because serotonin can cause a powerful cardiogenic hypertensive chemoreflex, we suggest that such a response may dislodge early platelet aggregations. Lessons from TTP may have special relevance for better understanding of myocardial reperfusion problems associated with angioplasty, thrombolysis and ischemic preconditioning.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction

